Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Hendrickx

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 3, 2025
Difference in Exposure and Tolerability when Comparing Intratracheal Instillation with Inhaled DeliveryMikael Brülls, Elin Holmedal, Ramon Hendrickx
Journal of Medicinal Chemistry|August 30, 2013
Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2Ramon Hendrickx, Jenny G Johansson, Christina Lohmann, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 28, 2017
Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilatorsRamon Hendrickx, Eva Lamm Bergström, David L I Janzén, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2016
Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulatorsMartin Hemmerling, Karl Edman, Matti Lepistö, et al.
Archives of Toxicology|May 28, 2024
A novel in vitro high-content imaging assay for the prediction of drug-induced lung toxicityPaul A Fitzpatrick, Julia Johansson, Gareth Maglennon, et al.
Journal of Medicinal Chemistry|September 22, 2023
Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical CharacterizationMagnus Nilsson, Kristina Berggren, Susanne Berglund, et al.
Skin Health and Disease|June 5, 2023
Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areataJohan Mattsson, Elisabeth Israelsson, Karin Björhall, et al.
The Lancet. Rheumatology|January 23, 2024
Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trialsTove Hegelund Myrbäck, Susanne Prothon, Karl Edman, et al.
Journal of Medicinal Chemistry|February 10, 2018
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect ProfileLena Ripa, Karl Edman, Matthew Dearman, et al.
Drug Design, Development and Therapy|September 7, 2022
Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of AsthmaMagnus Nilsson, Magdalena Rhedin, Ramon Hendrickx, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 3, 2025
Difference in Exposure and Tolerability when Comparing Intratracheal Instillation with Inhaled DeliveryMikael Brülls, Elin Holmedal, Ramon Hendrickx
Journal of Medicinal Chemistry|August 30, 2013
Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2Ramon Hendrickx, Jenny G Johansson, Christina Lohmann, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 28, 2017
Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilatorsRamon Hendrickx, Eva Lamm Bergström, David L I Janzén, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2016
Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulatorsMartin Hemmerling, Karl Edman, Matti Lepistö, et al.
Archives of Toxicology|May 28, 2024
A novel in vitro high-content imaging assay for the prediction of drug-induced lung toxicityPaul A Fitzpatrick, Julia Johansson, Gareth Maglennon, et al.
Journal of Medicinal Chemistry|September 22, 2023
Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical CharacterizationMagnus Nilsson, Kristina Berggren, Susanne Berglund, et al.
Skin Health and Disease|June 5, 2023
Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areataJohan Mattsson, Elisabeth Israelsson, Karin Björhall, et al.
The Lancet. Rheumatology|January 23, 2024
Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trialsTove Hegelund Myrbäck, Susanne Prothon, Karl Edman, et al.
Journal of Medicinal Chemistry|February 10, 2018
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect ProfileLena Ripa, Karl Edman, Matthew Dearman, et al.
Drug Design, Development and Therapy|September 7, 2022
Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of AsthmaMagnus Nilsson, Magdalena Rhedin, Ramon Hendrickx, et al.
Pageof 2